101 related articles for article (PubMed ID: 20332450)
1. Combined gamma-tocotrienol and erlotinib/gefitinib treatment suppresses Stat and Akt signaling in murine mammary tumor cells.
Bachawal SV; Wali VB; Sylvester PW
Anticancer Res; 2010 Feb; 30(2):429-37. PubMed ID: 20332450
[TBL] [Abstract][Full Text] [Related]
2. Enhanced antiproliferative and apoptotic response to combined treatment of gamma-tocotrienol with erlotinib or gefitinib in mammary tumor cells.
Bachawal SV; Wali VB; Sylvester PW
BMC Cancer; 2010 Mar; 10():84. PubMed ID: 20211018
[TBL] [Abstract][Full Text] [Related]
3. Combined treatment of gamma-tocotrienol with statins induce mammary tumor cell cycle arrest in G1.
Wali VB; Bachawal SV; Sylvester PW
Exp Biol Med (Maywood); 2009 Jun; 234(6):639-50. PubMed ID: 19359655
[TBL] [Abstract][Full Text] [Related]
4. gamma-Tocotrienol inhibits ErbB3-dependent PI3K/Akt mitogenic signalling in neoplastic mammary epithelial cells.
Samant GV; Sylvester PW
Cell Prolif; 2006 Dec; 39(6):563-74. PubMed ID: 17109639
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms mediating the synergistic anticancer effects of combined γ-tocotrienol and sesamin treatment.
Akl MR; Ayoub NM; Sylvester PW
Planta Med; 2012 Nov; 78(16):1731-9. PubMed ID: 22987298
[TBL] [Abstract][Full Text] [Related]
6. Gamma-tocotrienol inhibits neoplastic mammary epithelial cell proliferation by decreasing Akt and nuclear factor kappaB activity.
Shah SJ; Sylvester PW
Exp Biol Med (Maywood); 2005 Apr; 230(4):235-41. PubMed ID: 15792944
[TBL] [Abstract][Full Text] [Related]
7. Synergistic antiproliferative effects of gamma-tocotrienol and statin treatment on mammary tumor cells.
Wali VB; Sylvester PW
Lipids; 2007 Dec; 42(12):1113-23. PubMed ID: 17701065
[TBL] [Abstract][Full Text] [Related]
8. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
Sylvester PW; Shah S
Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
[TBL] [Abstract][Full Text] [Related]
9. Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor.
Huang S; Armstrong EA; Benavente S; Chinnaiyan P; Harari PM
Cancer Res; 2004 Aug; 64(15):5355-62. PubMed ID: 15289342
[TBL] [Abstract][Full Text] [Related]
10. First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway.
Manu KA; Shanmugam MK; Ramachandran L; Li F; Fong CW; Kumar AP; Tan P; Sethi G
Clin Cancer Res; 2012 Apr; 18(8):2220-9. PubMed ID: 22351692
[TBL] [Abstract][Full Text] [Related]
11. Oxazine derivatives of γ- and δ-tocotrienol display enhanced anticancer activity in vivo.
Ananthula S; Parajuli P; Behery FA; Alayoubi AY; El Sayed KA; Nazzal S; Sylvester PW
Anticancer Res; 2014 Jun; 34(6):2715-26. PubMed ID: 24922632
[TBL] [Abstract][Full Text] [Related]
12. Synergistic anticancer effects of combined gamma-tocotrienol and celecoxib treatment are associated with suppression in Akt and NFkappaB signaling.
Shirode AB; Sylvester PW
Biomed Pharmacother; 2010 May; 64(5):327-32. PubMed ID: 19954924
[TBL] [Abstract][Full Text] [Related]
13. Anti-proliferative effects of γ-tocotrienol are associated with suppression of c-Myc expression in mammary tumour cells.
Parajuli P; Tiwari RV; Sylvester PW
Cell Prolif; 2015 Aug; 48(4):421-35. PubMed ID: 26096843
[TBL] [Abstract][Full Text] [Related]
14. Sesamin synergistically potentiates the anticancer effects of γ-tocotrienol in mammary cancer cell lines.
Akl MR; Ayoub NM; Abuasal BS; Kaddoumi A; Sylvester PW
Fitoterapia; 2013 Jan; 84():347-59. PubMed ID: 23266736
[TBL] [Abstract][Full Text] [Related]
15. Influence of gefitinib and erlotinib on apoptosis and c-MYC expression in H23 lung cancer cells.
Suenaga M; Yamamoto M; Tabata S; Itakura S; Miyata M; Hamasaki S; Furukawa T
Anticancer Res; 2013 Apr; 33(4):1547-54. PubMed ID: 23564796
[TBL] [Abstract][Full Text] [Related]
16. Role of Rac1/WAVE2 Signaling in Mediating the Inhibitory Effects of γ-Tocotrienol on Mammary Cancer Cell Migration and Invasion.
Algayadh IG; Dronamraju V; Sylvester PW
Biol Pharm Bull; 2016; 39(12):1974-1982. PubMed ID: 27904039
[TBL] [Abstract][Full Text] [Related]
17. Intracellular signaling mechanisms mediating the antiproliferative and apoptotic effects of gamma-tocotrienol in neoplastic mammary epithelial cells.
Sylvester PW; Shah SJ; Samant GV
J Plant Physiol; 2005 Jul; 162(7):803-10. PubMed ID: 16008108
[TBL] [Abstract][Full Text] [Related]
18. Endoplasmic reticulum stress mediates gamma-tocotrienol-induced apoptosis in mammary tumor cells.
Wali VB; Bachawal SV; Sylvester PW
Apoptosis; 2009 Nov; 14(11):1366-77. PubMed ID: 19771520
[TBL] [Abstract][Full Text] [Related]
19. Combined inhibition of IGFR enhances the effects of gefitinib in H1650: a lung cancer cell line with EGFR mutation and primary resistance to EGFR-TK inhibitors.
Choi YJ; Rho JK; Jeon BS; Choi SJ; Park SC; Lee SS; Kim HR; Kim CH; Lee JC
Cancer Chemother Pharmacol; 2010 Jul; 66(2):381-8. PubMed ID: 19921194
[TBL] [Abstract][Full Text] [Related]
20. Suppression of cell proliferation and gene expression by combinatorial synergy of EGCG, resveratrol and gamma-tocotrienol in estrogen receptor-positive MCF-7 breast cancer cells.
Hsieh TC; Wu JM
Int J Oncol; 2008 Oct; 33(4):851-9. PubMed ID: 18813800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
